| GEM (n = 36) | BV (n = 34) | Total (n = 70) | p-value |
---|---|---|---|---|
Males | 16 (44.4%) | 24 (70.6%) | 40 (57.1%) | 0.087 |
Age [years] (Median, IQR) | 35.3 (30.0, 40.5) | 36.9 (31.0, 44.1) | 35.6 (30.6, 41.6) | 0.565 |
Stage: | ||||
 0 | 1 (2.8%) | 1 (2.9%) | 2 (2.9%) | 1.000 |
 1 | 35 (97.2%) | 33 (97.1%) | 68 (97.1%) | |
ECOG PS: | ||||
 0 | 19 (52.8%) | 14 (41.2%) | 33 (47.1%) | 0.286 |
 1 | 17 (47.2%) | 17 (50.0%) | 34 (48.6%) | |
 2 | 0 (0.0%) | 2 (5.9%) | 2 (2.9%) | |
 3 | 0 (0.0%) | 1 (2.9%) | 1 (1.4%) | |
CD4-cells/μL (Median, IQR) | 225.0 (108.5, 310.0) | 222.0 (63.8, 431.0) | 224.0 (107.0, 360.5) | 0.914 |
BSA [m2] (Median, IQR) | 1.57 (1.50, 1.70) | 1.67 (1.58, 1.79) | 1.60 (1.50, 1.74) | 0.0872 |
Duration of HIV diagnosis [months] (Median, IQR) | 14.5 (4.8, 66.8) | 12.0 (6.3, 38.0) | 12.0 (6.0, 53.5) | 0.722 |
Duration of AIDS-KS confirmed diagnosis [weeks] (Median, IQR) | 5.4 (3.9, 8.8) | 4.3 (3.0, 7.9) | 4.8 (3.7, 8.6) | 0.300 |